The pharmacokinetics and neuropharmacological action of the new antiepileptic drugs vigabatrin and levetiracetam
Epilepsy affects approximately 1% of the world population and is the most serious neurological conditions. In the UK, 30-35,000 new cases of epilepsy are diagnosed each year, resulting in a prevalence of 300,000 nationwide. There is significant need for new drug treatments. Yet we have a poor unders...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2007
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.444576 |